The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature
Open accessAbstract
BACKGROUND: There are several methods of assessing nutritional status in cancer of which serum albumin is one of the most commonly used. In recent years, the role of malnutrition as a predictor of survival in cancer has received considerable attention. As a result, it is reasonable to investigate whether serum albumin has utility as a prognostic indicator of cancer survival in cancer. This review summarizes all available epidemiological literature on the association between pretreatment serum albumin levels and survival in different types of cancer. METHODS: A systematic search of the literature using the MEDLINE database (January 1995 through June 2010) to identify epidemiologic studies on the relationship between serum albumin and cancer survival. To be included in the review, a study must have: been published in English, reported on data collected in humans with any type of cancer, had serum albumin as one of the or only predicting factor, had survival as one of the outcome measures (primary or secondary) and had any of the following study designs (case-control, cohort, cross-sectional, case-series prospective, retrospective, nested case-control, ecologic, clinical trial, meta-analysis). RESULTS: Of the 29 studies reviewed on cancers of the gastrointestinal tract, all except three found higher serum albumin levels to be associated with better survival in multivariate analysis. Of the 10 studies reviewed on lung cancer, all excepting one found higher serum albumin levels to be associated with better survival. In 6 studies reviewed on female cancers and multiple cancers each, lower levels of serum albumin were associated with poor survival. Finally, in all 8 studies reviewed on patients with other cancer sites, lower levels of serum albumin were associated with poor survival. CONCLUSIONS: Pretreatment serum albumin levels provide useful prognostic significance in cancer. Accordingly, serum albumin level could be used in clinical trials to better define the baseline risk in cancer patients. A critical gap for demonstrating causality, however, is the absence of clinical trials demonstrating that raising albumin levels by means of intravenous infusion or by hyperalimentation decreases the excess risk of mortality in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“both responses to inflammation shown to be strongly prognostic across cancer types and treatment settings 27,28 .”
From A gut microbial signature for combination immune checkpoint blockade across cancer types (2024) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prognostic effect of weight loss prior tochemotherapy in cancer patients
Dewys, W. D., Begg, C., Lavin, P. T., Band, P. R., Bennett, J. M., Bertino, J. R., Cohen, M. H., Douglass, H. O., Engstrom, P. F., Ezdinli, E. Z., et al. (1980) · The American Journal of Medicine · doi:10.1016/s0149-2918(05)80001-3 · Cited by 2,354 · cited 1×
“treatment, increased risk of chemotherapy-induced toxicity and a reduction in cancer survival [14].”
Background(2012) · Hepatogastroenterology · doi:10.5754/hge12458 · Cited by 1,977
Bauer, J., Capra, S., & Ferguson, M. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601412 · Cited by 1,178 · cited 4×
“Among the most commonly used tools to measure nutritional status are subjective global assessment (SGA) [16-18], bioelectrical impedance analysis (BIA) [19], and laboratory measurements of serum albumin [20], preal-bumin, and transferrin [21,22].”
MethodInfluentialGibbs, J. (1999) · Archives of Surgery · doi:10.1001/archsurg.134.1.36 · Cited by 1,005 · cited 1×
“In the hospital setting, many reports have related serum albumin level to in-hospital mortality [35-38], length of stay (LOS) [39-41], and nosocomial infection [36,42].”
BackgroundMcMillan, D. C., Crozier, J. E. M., Canna, K., Angerson, W. J., & McArdle, C. S. (2007) · International Journal of Colorectal Disease · doi:10.1007/s00384-006-0259-6 · Cited by 533
Impact of body mass index and albumin on morbidity and mortality after cardiac surgery
Engelman, D. T., Adams, D. H., Byrne, J. G., Aranki, S. F., Collins, J. J., Couper, G. S., Allred, E. N., Cohn, L. H., & Rizzo, R. J. (1999) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(99)70056-5 · Cited by 493 · cited 1×
“In the hospital setting, many reports have related serum albumin level to in-hospital mortality [35-38], length of stay (LOS) [39-41], and nosocomial infection [36,42].”
BackgroundMcMillan, D. C., Watson, W. S., O'Gorman, P., Preston, T., Scott, H. R., & McArdle, C. S. (2001) · Nutrition and Cancer · doi:10.1207/s15327914nc392_8 · Cited by 461 · cited 2×
“icantly and serve as good indicators of prognosis of cancer [33,34].”
BackgroundRisk factors for morbidity and mortality after colectomy for colon cancer
Longo, W. E., Virgo, K. S., Johnson, F. E., Oprian, C. A., Vernava, A. M., Wade, T. P., Phelan, M. A., Henderson, W. G., Daley, J., & Khuri, S. F. (2000) · Diseases of the Colon & Rectum · doi:10.1007/bf02237249 · Cited by 416 · cited 1×
“In the hospital setting, many reports have related serum albumin level to in-hospital mortality [ 35-38 ], length of stay (LOS) [39-41], and nosocomial infection [36,42].”
BackgroundDetsky, A. S., Baker, J. P., Mendelson, R. A., Wolman, S. L., Wesson, D. E., & Jeejeebhoy, K. N. (1984) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607184008002153 · Cited by 412
Nutritional Assessment of the Hospitalized Patient
Blackburn, G. L., & Thornton, P. A. (1979) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31663-7 · Cited by 372
Cited by
Human serum albumin: From bench to bedside
Fanali, G., di Masi, A., Trezza, V., Marino, M., Fasano, M., & Ascenzi, P. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.12.002 · Cited by 1,931
Levitt, D., & Levitt, M. (2016) · International Journal of General Medicine · doi:10.2147/ijgm.s102819 · Cited by 763
Cupp, M. A., Cariolou, M., Tzoulaki, I., Aune, D., Evangelou, E., & Berlanga-Taylor, A. J. (2020) · BMC Medicine · doi:10.1186/s12916-020-01817-1 · Cited by 697
Exploiting the critical perioperative period to improve long-term cancer outcomes
Horowitz, M., Neeman, E., Sharon, E., & Ben-Eliyahu, S. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.224 · Cited by 487
Cespedes Feliciano, E. M., Kroenke, C. H., Meyerhardt, J. A., Prado, C. M., Bradshaw, P. T., Kwan, M. L., Xiao, J., Alexeeff, S., Corley, D., Weltzien, E., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.2319 · Cited by 427
“5g/dL (thecutoff forhypoalbuminemia; to convert to grams per liter, multiply by 10).(14)”
Metadata
- Authors
- Gupta, D., & Lis, C. G.
- Affiliations
- Cancer Treatment Centers of America (US)
- Corresponding author
- Lis, Christopher G
- ORCID
- Gupta, Digant
- Venue
- Nutrition Journal
- Published
- 2010-12
- Volume
- 9
- Issue
- 1
- Pages
- 69-69
- ISSN
- 1475-2891 (ISSN-L)
- PMC
- PMC3019132
- OpenAlex
- W2167127503
- Cited by
- 1,485
- References
- 98
- Citations by year
- 2026: 122 · 2025: 147 · 2024: 138 · 2023: 152 · 2022: 161 · 2021: 178 · 2020: 140 · 2019: 86 · 2018: 83 · 2017: 72 · 2016: 64 · 2015: 56 · 2014: 34 · 2013: 24 · 2012: 11
- FWCI
- 1.70
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrition Journal (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
- Keywords
- serum albumin, cancer survival, prognostic factors, malnutrition, nutritional status, gastrointestinal cancer, lung cancer, women's cancer, multiple primary neoplasms, mortality risk
- MeSH terms
- Female, Humans, Male, Neoplasms, Prognosis, Serum Albumin, Nutrition Assessment, Malnutrition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature. https://app.cochat.ai/papers/10.1186/1475-2891-9-69
- The paper
- Gupta, D., & Lis, C. G. (2010). Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature. Nutrition Journal. https://doi.org/10.1186/1475-2891-9-69
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.